arrow
B

Bas W.G. van Rhijn

 department of urology
H指数:53
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical impact of routine second‑opinion reading of [¹⁸F]FDG‑PET/CT in newly diagnosed invasive bladder cancer: A multicentre study in a centralised referral network

对中央化转诊网络中新诊断浸润性膀胱癌进行常规[¹⁸F]FDG‑PET/CT二次读片的临床影响:一项多中心研究

2026-08-250
OAAI
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group

活性监测和化疗消融在非肌层浸润性膀胱癌(NMIBC)管理中的有效性与安全性:欧洲泌尿外科学会青年学术泌尿外科医生:尿路上皮癌工作组的系统评价和合并分析

2026-03-010
PRE
Applicability of the European Association of Urology 2021 Prognostic Model for Non–muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

欧洲泌尿外科学会2021年非肌层浸润性膀胱癌预后模型在瑞典基于人群队列中的适用性

2025-09-040
PREAI
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer

关于为原发性中危非肌肉浸润性膀胱癌患者定义随访策略的研究

2025-05-210
PRE
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update

欧洲泌尿外科学会上尿路尿路上皮癌指南:2025年更新摘要

2025-03-200
PRE
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels

膀胱癌根治性膀胱切除术后随访的一致性:基于欧洲泌尿外科学会膀胱癌指南专家组协作开发专家实践框架

2025-02-012
PRE
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non–muscle-invasive Bladder Cancer

系统评价与Meta分析:预防性喹诺酮类药物联合佐剂卡介苗灌注对非肌层浸润性膀胱癌的临床影响

2025-01-010
PRE
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines

根治性肾输尿管切除术作为区域性淋巴结转移临床证据的上尿路尿路上皮癌患者多模式治疗策略的一部分:其利弊分析——欧洲泌尿外科学会指南的系统评价和荟萃分析

2025-01-010
PRE
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review

膀胱癌根治性膀胱切除术后随访的变化-库存圆桌会议和文献综述

2024-04-300
OAAI
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes

提出一种新的组织学评分系统,作为与疾病侵袭性和患者预后相关的肌肉浸润性尿路上皮膀胱癌的潜在分级方法

2024-02-017
OA
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes (Aug, 10.1016/j.euo.2023.07.011, 2023)
2023-12-011
OA
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

欧洲泌尿外科协会上尿路尿路上皮癌指南: 2023更新

2023-07-01212
OA
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer (vol 83, pg 313, 2023)
2023-06-010
OA
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
2023-06-014
OAAI
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
2023-05-018
PRE
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel (vol 79, pg 480, 2021)
2023-05-010
OA